Prevent Blindness has designated November 18 to 24, 2024, as the 5th annual Thyroid Eye Disease (TED) Awareness Week. The ...

Topline data from Phase 2b/3 trial of izokibep as a treatment for non-infectious non-anterior uveitis expected in December 2024 Positive lonigutamab EOP2 FDA interaction completed and initiation of ...

Ocular autoimmune disease involves the immune system attacking the tissues of the eye. These diseases typically manifest through an autoantibody response targeting the retina, uvea, vitreous, and ...

The treatment for Hashimoto's disease is determined by whether your thyroid has been damaged sufficiently to induce ...

Medically reviewed by Kelly Wood, MD Hypothyroidism—or an underactive thyroid—is a condition that happens when the thyroid ...

A joint presentation by an endocrinologist and ophthalmologist reviewed best practices for managing thyroid eye disease, ...

These drugs are collectively known as GLP-1 agonists because they mimic the body’s natural hormone GLP-1, which regulates ...

A preliminary study showed first evidence of normalization of T3, T4, within weeks, with additional thyroid eye disease effects.

Sources suggest Donald Trump is considering Robert F Kennedy Jr for a key healthcare role focused on childhood chronic diseases if re-elected. Kennedy, known for his controversial anti-vaccine ...

One of its lead pipeline assets, HL161 (INN: batoclimab), an anti-FcRn antibody, is being developed in Phase 3 and Phase 2 ...

Noah S. Kalman, MD, MBA, highlighted advancements in thyroid cancer treatment, emphasizing personalized therapies, molecular ...